Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qi-Zheng-Xiao-Tong Plaster is a traditional Tibetan medicated plaster developed and manufactured by Tibet Qizheng Tibetan Medicine. It is primarily composed of *Lamiophlomis rotata* and *Curcuma longa* (turmeric) within a hydrophilic adhesive vehicle. The plaster is indicated for the treatment of chronic pain and inflammation associated with musculoskeletal conditions, specifically knee osteoarthritis. In clinical research, it is often used as a positive control comparator for other traditional Chinese medicine (TCM) topical treatments. Its mechanism involves the anti-inflammatory and analgesic properties of its herbal constituents, which are delivered transdermally to the affected joint. The drug has received approval from the State Food and Drug Administration (SFDA) in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qi-Zheng-Xiao-Tong Plaster.